Rank #1501RARE

Ultragenyx Pharmaceutical Inc.

$21.83

6.75% (Daily)

Market Cap

$2.11B

Revenue

$673.00M

Rank by MCap

#1501

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Emil D. Kakkis M.D., Ph.D.

Headquarters

Novato, CA

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Meps...